Industry News
Cold gases and 'hot' superconductors
There may be a relatively simple, shared explanation for equivalent behaviours of ultracold atomic gases and high-temperature superconductors.
[ + ]Using ultrasound to control toxic algal blooms
Ultrasound is being investigated by University of Adelaide researchers as an environmentally friendly way of controlling blue-green algal blooms in fresh water supplies.
[ + ]Sigma rejects revised offer from Aspen
Melbourne biotech Sigma Pharmaceuticals has assured shareholders that it is trying to negotiate a better deal than the revised $0.55 a share offered for the company by South African generics producer Aspen Pharmacare Holdings. [ + ]
Qiagen appoints chief medical officer
Dr Ellen Sheets has been appointed to lead Qiagen’s biomarker discovery strategy and its evaluation program for new molecular diagnostic content.
[ + ]Market Report: Shares rise on strong jobs figures and a resurgent Wall Street
The Australian stock market managed its strongest close in a month today spurred by better-than-expected Australian employment data as well as improved confidence in the U.S economy following three days of consecutive gains on Wall Street. [ + ]
U.S scientists identify chemicals that grow brain cells
Researchers at the Emory University School of Medicine in Atlanta have identified chemicals that help to grow neurons in the brains of mice, potentially leading to new treatments for mental illness and cognitive disabilities. [ + ]
Avexa appoints new chairman
HIV drug company Avexa has appointed industry veteran Joe Baini as its new chairman after shareholders voted on Tuesday to remove his predecessor Nathan Drona and virtually the company’s entire board. [ + ]
Clinuvel signs first manufacturing deal for Scenesse
Melbourne biotech Clinuvel (ASX:CUV) has struck the first commercial manufacturing deal for its UV-protection drug Scenesse. [ + ]
Sales of generic HIV drugs to surge as patents expire
Sales of generic HIV drugs will double to more than $US1.2 billion by 2019 making up 10 percent of the entire retroviral market, according to industry analysts Datamonitor. [ + ]
AusBiotech positive about working with Julia Gillard
Peak industry body AusBiotech said today that it was confident of working with new prime minister Julia Gillard to develop a more effective legislative framework for the Australian biotechnology industry. [ + ]
AtCor adds to run of sales since March
AtCor Medical announced today that it has signed a US$1.77 million contract for the supply of its SphygmoCor blood pressure measurement system to a U.S customer. [ + ]
Avexa axes board
Shareholders in Avexa today voted resoundingly in favour of ousting existing chairman and director Nathan Drona along with the company’s entire board. [ + ]
Patrys granted U.S patent for lead human anti-body product
Patrys announced today that it has received a U.S patent for its lead product PATPM1, a promising new human antibody shown to be effective in the treatment of solid tumors and metastases across a number of indicators including pancreatic, lung, breast, colon and gastric cancers. [ + ]
Study reveals genes that fight genes may hold key to longevity
A study of the genomes of 1000 centenarians in New England has highlighted 150 variations of DNA sequence which the researchers claim indicate with 77 percent accuracy whether someone will reach a century. [ + ]
Market Report: fears of double dip U.S recession continue to haunt
Australian shares staged a small comeback on Friday ending eight days of consecutive losses incured as investors eyed the looming spectre of a double-dip recession in the U.S, while data out of China showed that measures aimed at slowing its economy were working. [ + ]